StockStory.org on MSN
ICUI Q3 Deep Dive: Strategic Execution Drives Margin Gains Amid Revenue Headwinds
Medical device company ICU Medical (NASDAQ:ICUI) reported in Q3 CY2025, but sales fell by 8.9% year on year to $537 million.
ASX extends losses as investors sell out of rare earths; China plans mega African iron ore mine; BlueScope names new CEO; ...
Eli Lilly and Novo are preparing to announce new drug pricing deals with the White House, including for their blockbuster weight loss drugs. Blackstone Life Sciences will pay Merck $700 million for ...
European chip stocks rise as investors pivot to niche AI hardware, eyeing potential winners like Axelera AI, emblematic of Europe’s push into specialized AI silicon for edge ...
The rise of AI could give patients more control over their healthcare journeys, but successful implementation brings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results